The lung is a target organ in sickle cell anemia. Because its capillar
y network is well developed, it is often the site of infection and thr
ombosis, which lead to acute and/or chronic pulmonary manifestations.
Hypoxia with a decrease in arterial blood oxygen content, a paradoxica
l increase in the partial pressure of oxygen in venous blood, and redu
ced affinity of oxygen for the abnormal hemoglobin are the most signif
icant pathophysiologic factors. The cardiac index is consistently incr
eased, as a result of both tachycardia and an increase in systolic str
oke volume. Peripheral arterial resistance is nearly halved at rest an
d during exercise. The compensatory changes seem out of proportion wit
h the severity of the anemia, and there is a paradoxical decrease in t
he peripheral extraction of oxygen. The main acute pulmonary complicat
ion is acute chest syndrome (ACS), with chest pain, dyspnea and abnorm
al physical findings upon examination of the chest. ACS can be produce
d by a thoracic vasooclusive crisis or a life-threatening complication
such as pulmonary thrombosis or embolism, infection, alveolar hypoven
tilation, or pulmonary edema. Sickle cell anemia is responsible for fa
ilure to thrive with decreased chest size and lung size. Lung function
tests are normal during childhood. Pulmonary fibrosis and pulmonary h
ypertension can develop in adulthood as a result of recurrent episodes
of microvascular occlusion. Early diagnosis of pulmonary complication
s and close lung function monitoring are essential. It would be of use
to determine the factors associated with an increased risk of pulmona
ry abnormalities in sickle cell anemia patients.